The Care Ledger

The market Jefferson Health loses $81 million in a quarter as it presses insurers for higher rates

Search
Tuesday, November 17, 2026Today's Paper From the publisher Free hospital price search Published bysoro
The Care Ledger

The market

Jefferson Health loses $81 million in a quarter as it presses insurers for higher rates

Philadelphia's largest health system is using weak results to argue for higher commercial rates, six weeks before its contracts with three Blue Cross insurers expire.

A Thomas Jefferson University Hospital building on Chestnut Street in Philadelphia
A Jefferson building on Chestnut Street in Philadelphia, part of the Thomas Jefferson University Hospital campus. Photo: David Saddler, via Wikimedia Commons (CC BY 2.0)

Jefferson Health lost $81 million on operations in the three months ended September 30, the first quarter of its 2027 fiscal year, the Philadelphia Inquirer reported1 on Friday from results the system shared with bondholders. The loss came as Jefferson negotiates new contracts with Independence Blue Cross, Highmark and Horizon Blue Cross Blue Shield of New Jersey, all of which run out on December 31.

Jefferson's chief financial officer, Mike Harrington, tied the results directly to those talks. He said the system is seeking higher payment rates and pointed to inflation and to what he called insurers' unilateral changes to their reimbursement policies, according to the Inquirer.

Hospital contract talks set the prices that employers and their workers pay through premiums, deductibles and coinsurance. Whatever rate increase Jefferson wins from Independence, the dominant insurer in the Philadelphia region, flows into the cost of coverage for the employers that buy Independence plans.

If the talks fail, the cost moves to patients in a different way. A health system that leaves an insurer's network can bill that insurer's members at out-of-network rates, which usually means higher out-of-pocket costs for anything other than emergency care.

Revenue rose 8% to $4.34 billion, up from $4 billion a year earlier, the Inquirer reported. Patient revenue grew 4%, revenue from Jefferson's own insurance business grew 21%, and other revenue grew 16%.

The loss would have been larger without investment income. Jefferson, which includes Thomas Jefferson University, follows higher education accounting rules that let it count $75 million of investment income as operating revenue. Without that income, the operating loss would have been $156 million.

The year-earlier loss was $104 million, and it included $19.4 million of restructuring costs. Admissions rose 2.3% to 64,370, while surgical procedures dipped slightly to about 47,700. The disclosure gave no reason for the decline in surgeries, the Inquirer reported.

The two sides describe Independence's rates very differently. Jefferson says Independence pays it about 40% below national averages and wants significant increases, the Inquirer reported on November 62. Independence says its rates to Jefferson are competitive for the local market and that it has offered a significant increase.

Highmark has said it is still negotiating in good faith, according to the same report.

The Pennsylvania Insurance Department said on November 6 that it will step in if there is no deal with Independence or Highmark by December 31. Under Act 94, a 1975 state law that applies only to Blue Cross and Blue Shield plans, the insurance commissioner can suspend a contract termination for up to six months, hold public hearings and bring in an arbitrator. Regulators cannot force the two sides to sign a contract, the Inquirer reported. Independence said it gave the department the required 90 days' notice that the contract could end on December 31.

The contracts expire at the end of the day on December 31. If Jefferson and Independence or Highmark have not reached a deal by then, the Pennsylvania Insurance Department can use its Act 94 powers to keep the contract in force while the two sides keep talking. The state law does not cover Horizon, which is regulated in New Jersey.

Jefferson's next quarterly results, for the three months ending December 31, would show whether the system has made up ground on costs while the talks continue.

  • 01

    Cassidy's office says a surprise-billing bill is coming soon

    An aide to Sen. Bill Cassidy said the senator's proposal to overhaul the No Surprises Act's arbitration process will be released soon, and a Georgetown researcher said disputes are on track to top 4 million this year, up from about 2.5 million in 2025.

    Healthcare Dive

  • 02

    Hillcrest and Aetna talks have broken off in Tulsa.

    Hillcrest says negotiations have stopped, more than two weeks after its hospitals and doctors left Aetna's commercial and Medicare networks, a split it says affects more than 15,000 Oklahomans. Aetna says Hillcrest sought price increases that would significantly raise costs for members and employers.

    FOX23

  • 03

    Private equity home health buyers cut visits and Medicare pay per episode

    A study in JAMA Health Forum of 165 home health agencies bought by private equity found visits per episode fell 8.3% and Medicare payment per episode fell 3.1%, or $73.85, compared with similar agencies. The authors say one large acquisition drives much of the result.

    JAMA Health Forum

Every figure in this story was checked against these sources on Monday, November 16, 2026.

  1. 01Philadelphia Inquirer, "Jefferson Health financial results, fiscal 2027 first quarter", November 13, 2026inquirer.com
  2. 02Philadelphia Inquirer, "Jefferson, Highmark and IBX insurance contract talks", November 6, 2026inquirer.com
  3. 03Healthcare Dive, "Cassidy aide pledges No Surprises fix coming soon", November 13, 2026healthcaredive.com
  4. 04FOX23, "No progress between Hillcrest and Aetna", November 13, 2026fox23.com
  5. 05JAMA Health Forum, "Private equity acquisition of home health agencies", November 13, 2026jamanetwork.com
  6. PhotoA Jefferson building on Chestnut Street in Philadelphia, part of the Thomas Jefferson University Hospital campus. Photo: David Saddler, via Wikimedia Commons (CC BY 2.0).commons.wikimedia.org
  1. The market

    Maryland finalizes the first state payment limits on a drug, for Ozempic and Jardiance

    Starting in January, state and local government health plans in Maryland can cap what they pay for the two drugs, and a 2025 law lets the board extend the limits to private insurance from 2028.

    3 min read

  2. The market

    CVS says GLP-1 drugs would pay for themselves at about $350 a month

    CVS Health's own claims study finds that weight-loss and diabetes drugs cut hospital use but still raise what employers and plans spend per member, and it names the net price at which that would stop.

    3 min read

  3. The market

    Surgery Partners rejects a $28 bid, takes $25 a share from Bon Secours Mercy's HealthSpan

    The surgery center chain chose a hospital system's raised offer over a higher cash bid, reported to be UnitedHealth's, because the board judged the bigger number less likely to close.

    3 min read

  4. The market

    Biotech groups file the second lawsuit against Medicare's international drug price pilot

    BIO and two California trade groups asked a federal court on Friday to throw out the GLOBE model, which from January ties Medicare Part B rebates on certain drugs to prices in 19 other countries.

    3 min read